Michael Togobo

Obstetrics and Gynaecology , Midyorkshire NHS Trust
  • Midyorkshire NHS Trust
  • United Kingdom

Recent Comments

Apr 13, 2021

Hi,

Sending a second request to ask if you could provide us with for final scores for pelvic pain, dysmenorrhoea and dyspareunia in order to enable us to perform a meta-analysis with other papers to identify the effectiveness of GnRH anatagonists in the management of endometriotic pain. 

Many thanks  

Apr 13, 2021

Hi, I am sending a second request regarding obtaining further information on the final scores on dysmenorrhoea, non menstrual pelvic pain, dyschezia, difficutly in doing daily activity and dyspareunia on the above article in order for us to perform a meta-analysis with other papers on the effectiveness of GnRH antagonists on endometriosis.  Many thanks 

Mar 21, 2021

I am part of a team currently working on a cochrane review on the benefits of GnRH antagonists as a treatment for endometriotic pain.  This trial has been selected for the meta-analysis.  Following discussions with our statistician we would like to ask the authors whether they could provide us with final scores (as appose to the change from baseline published in the paper) for pelvic pain, dysmenorrhoea and and dyspareunia.  This would help us enormously with the data analysis in the final meta-analysis.  Thank you

Mar 21, 2021

I am part of a team currently working on a cochrane review on the benefits of GnRH antagonists on the treatment for endometriotic pain.  Your study has been selected for the meta-analysis.  Following discussions with our statistician we would like to ask the authors whether they could provide us with final scores (as appose to the change in score or difference from placebo published in the paper) for dysmenorrhoea, non menstrual pelvic pain, dyschezia, difficulty in doing daily activity  and dyspareunia.  This would help us enormously with the data analysis in the final meta-analysis.

Many thanks